EDGAR Filing Documents for 0001654954-16-003935

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-16-003935

Filing Date

2016-11-14

Accepted

2016-11-14 15:02:48

Documents

Period of Report

2016-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	sbfm_10q.htm	10-Q	565935
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12834
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	12750
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	7431
5	IMAGE	sbfm_10q000.jpg	GRAPHIC	12555
6	IMAGE	sbfm_10q001.jpg	GRAPHIC	7537
	Complete submission text file	0001654954-16-003935.txt		1513670

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	sbfm-20160930.xml	EX-101.INS	92835
8	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20160930.xsd	EX-101.SCH	18133
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20160930_cal.xml	EX-101.CAL	35724
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20160930_def.xml	EX-101.DEF	18296
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20160930_lab.xml	EX-101.LAB	115859
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20160930_pre.xml	EX-101.PRE	85978

Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4

Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)